DexCom: Number of Employees 2010-2025 | DXCM

Interactive chart of DexCom (DXCM) annual worldwide employee count from 2010 to 2025.
  • DexCom total number of employees in 2024 was 10,300, a 7.29% increase from 2023.
  • DexCom total number of employees in 2023 was 9,600, a 26.32% increase from 2022.
  • DexCom total number of employees in 2022 was 7,600, a 8.57% increase from 2021.
  • DexCom total number of employees in 2021 was 7,000, a 9.38% increase from 2020.
DexCom Annual Employee Count
2024 10,300
2023 9,600
2022 7,600
2021 7,000
2020 6,400
2019 3,900
2018 2,800
2017 2,990
2016 2,300
2015 1,509
2014 1,061
2013 765
2012 698
2011 620
2010 520
2009 385
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $34.106B $4.033B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $197.994B 86.72
Thermo Fisher Scientific (TMO) United States $151.802B 18.36
Edwards Lifesciences (EW) United States $44.969B 29.49
Alcon (ALC) Switzerland $42.113B 28.46
IDEXX Laboratories (IDXX) United States $41.363B 47.53
STERIS (STE) Ireland $24.071B 26.54
Mettler-Toledo (MTD) United States $24.056B 28.61
IQVIA Holdings (IQV) United States $24.009B 13.45
Waters (WAT) United States $21.101B 29.77
SONOVA HOLDING (SONVY) Switzerland $18.538B 0.00
Hologic (HOLX) United States $14.197B 15.43
Sysmex ADR (SSMXY) Japan $10.588B 30.04
Penumbra (PEN) United States $10.235B 80.33
Masimo (MASI) United States $8.405B 31.00
Globus Medical (GMED) United States $8.016B 19.10
Glaukos (GKOS) United States $5.426B 0.00
Teleflex (TFX) United States $5.351B 8.83
TransMedics (TMDX) United States $4.350B 94.57
Integer Holdings (ITGR) United States $4.166B 21.83
PROCEPT BioRobotics (PRCT) United States $3.244B 0.00
LivaNova (LIVN) United Kingdom $2.333B 13.89
Nihon Kohden (NHNKY) Japan $2.223B 25.49
Veracyte (VCYT) United States $2.093B 29.36
Elekta AB (EKTAY) Sweden $2.075B 18.66
Alphatec Holdings (ATEC) United States $1.818B 0.00
Tandem Diabetes Care (TNDM) United States $1.409B 0.00
Artivion (AORT) United States $1.271B 119.04
Pulse Biosciences (PLSE) United States $1.206B 0.00
OPKO Health (OPK) United States $1.031B 0.00
Integra LifeSciences Holdings (IART) United States $0.987B 5.25
SiBone (SIBN) United States $0.788B 0.00
IRadimed (IRMD) United States $0.657B 33.33
RxSight (RXST) United States $0.654B 0.00
Beta Bionics (BBNX) United States $0.626B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.575B 8.94
Delcath Systems (DCTH) United States $0.564B 0.00
Mesa Laboratories (MLAB) United States $0.560B 13.18
AxoGen (AXGN) United States $0.499B 0.00
OrthoPediatrics (KIDS) United States $0.496B 0.00
Semler Scientific (SMLR) United States $0.461B 12.26
ORTHOFIX MEDICAL INC (OFIX) United States $0.443B 0.00
AngioDynamics (ANGO) United States $0.417B 0.00
NeuroPace (NPCE) United States $0.409B 0.00
Treace Medical Concepts (TMCI) United States $0.368B 0.00
ClearPoint Neuro (CLPT) United States $0.338B 0.00
Pacific Biosciences Of California (PACB) United States $0.330B 0.00
Neuronetics (STIM) United States $0.253B 0.00
Tactile Systems Technology (TCMD) United States $0.229B 13.86
908 Devices (MASS) United States $0.214B 0.00
Alpha Tau Medical (DRTS) Israel $0.210B 0.00
Sight Sciences (SGHT) United States $0.187B 0.00
Spectral Diagnostics (EDTXF) Canada $0.180B 0.00
CVRx (CVRX) United States $0.176B 0.00
Inogen (INGN) United States $0.176B 0.00
Anteris Technologies Global (AVR) Australia $0.171B 0.00
Lucid Diagnostics (LUCD) United States $0.164B 0.00
Accuray (ARAY) United States $0.164B 0.00
LENSAR (LNSR) United States $0.160B 0.00
Biosig Technologies (BSGM) United States $0.160B 0.00
Rapid Micro Biosystems (RPID) United States $0.143B 0.00
Atossa Genetics (ATOS) United States $0.105B 0.00
Microbot Medical (MBOT) United States $0.103B 0.00
Monogram Orthopaedics (MGRM) United States $0.094B 0.00
Sensus Healthcare (SRTS) United States $0.080B 48.40
InspireMD (NSPR) Israel $0.075B 0.00
EDAP TMS S.A (EDAP) France $0.066B 0.00
EnVVeno Medical (NVNO) United States $0.061B 0.00
Covalon Technologies (CVALF) Canada $0.051B 20.71
Hyperfine (HYPR) United States $0.047B 0.00
Vicarious Surgical (RBOT) United States $0.046B 0.00
Spectral AI (MDAI) United States $0.043B 0.00
Precision Optics (POCI) United States $0.036B 0.00
Envoy Medical (COCH) United States $0.034B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Baird Medical Investment Holdings (BDMD) $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.018B 0.00
NexGel (NXGL) United States $0.016B 0.00
WORK Medical Technology Group (WOK) China $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Ekso Bionics Holdings (EKSO) United States $0.011B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.001B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Nanovibronix (NAOV) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.45
Longview Acquisition II (LGV) United States $0.000B 0.00